AstraZeneca AB v. Mylan Pharms. Inc.
By EsqSocial Corporation 28/04/21
Symbicort® (budesonide and formoterol fumarate dihydrate) - Case Name: AstraZeneca AB v. Mylan Pharms. Inc., No. 1:18CV193, 2021 WL 798856 (N.D.W.V. Mar. 2, 2021) (Keeley, J.) - Drug Product and Patent(s)-in-Suit: Symbicort® (budesonide and formoterol fumarate dihydrate); U.S. Patents Nos. No. 7,759,328 (“the ’328 patent”), 8,143,239 (“the ’239 patent”), and 8,575,137 (“the ’137 patent”)....
By: Robins Kaplan LLP